{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:01:57Z","timestamp":1787860917278,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jns.2023.120584","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:19:01Z","timestamp":1676287141000},"page":"120584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Epilepsy and brain tumors: Two sides of the same coin"],"prefix":"10.1016","volume":"446","author":[{"given":"Eleonora","family":"Aronica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ciusani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salmaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Perversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/brain\/5.3.364","article-title":"Localised convulsions from tumour of the brain","volume":"5","author":"Hughlings-Jackson","year":"1882","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/157015912800604470","article-title":"Brain tumor-related epilepsy","volume":"10","author":"Maschio","year":"2012","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.jns.2023.120584_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2023.120584_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2019.10.018","article-title":"Current state and future perspective of drug repurposing in malignant glioma","volume":"68","author":"Siegelin","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.jns.2023.120584_bb0025","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","article-title":"Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients","volume":"268","author":"Stritzelberger","year":"2021","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40478-020-00904-x","article-title":"Low-grade developmental and epilepsy associated brain tumors: a critical update 2020","volume":"8","author":"Slegers","year":"2020","journal-title":"Acta Neuropathol Commun."},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","article-title":"Past and present definitions of epileptogenesis and its biomarkers","volume":"11","author":"Pitk\u00e4nen","year":"2014","journal-title":"Neurotherapeutics."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1528-1167.2011.03306.x","article-title":"Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy","volume":"53","author":"de Groot","year":"2012","journal-title":"Epilepsia."},{"issue":"Pt 4","key":"10.1016\/j.jns.2023.120584_bb0045","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/brain\/awr310","article-title":"Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment","volume":"135","author":"de Groot","year":"2012","journal-title":"Brain."},{"issue":"7775","key":"10.1016\/j.jns.2023.120584_bb0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature."},{"issue":"7775","key":"10.1016\/j.jns.2023.120584_bb0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211644","article-title":"AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro","volume":"14","author":"Lange","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jns.2023.120584_bb0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.jns.2023.120584_bb0070","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2012.03557.x","article-title":"Human glioma cells induce hyperexcitability in cortical networks","volume":"53","author":"Campbell","year":"2012","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2023.120584_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fncel.2011.00002","article-title":"A role for GAT-1 in presynaptic GABA homeostasis?","volume":"5","author":"Conti","year":"2011","journal-title":"Front. Cell. Neurosci."},{"issue":"244","key":"10.1016\/j.jns.2023.120584_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008065","article-title":"Cortical GABAergic excitation contributes to epileptic activities around human glioma","volume":"6","author":"Pallud","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0085","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/s41467-018-07113-0","article-title":"Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy","volume":"9","author":"Tewari","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jns.2023.120584_bb0090","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","article-title":"BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors","volume":"24","author":"Koh","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2023.120584_bb0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01267","article-title":"The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes","volume":"3","author":"McClelland","year":"2014","journal-title":"Elife."},{"issue":"6","key":"10.1016\/j.jns.2023.120584_bb0100","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1152\/jn.00523.2019","article-title":"BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons","volume":"123","author":"Goz","year":"2020","journal-title":"J. Neurophysiol."},{"issue":"8","key":"10.1016\/j.jns.2023.120584_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jns.2023.120584_bb0110","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/neuonc\/noac064","article-title":"PI3K\/AKT\/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications","volume":"24","author":"Mohamed","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2023.120584_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2018.01.011","article-title":"IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: a systematic review and meta-analysis","volume":"55","author":"Li","year":"2018","journal-title":"Seizure."},{"key":"10.1016\/j.jns.2023.120584_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yebeh.2017.10.027","article-title":"IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy","volume":"78","author":"Neal","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.jns.2023.120584_bb0125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1148\/radiol.2020191529","article-title":"Super-resolution whole-brain 3D MR spectroscopic imaging for mapping D-2-hydroxyglutarate and tumor metabolism in isocitrate dehydrogenase 1-mutated human gliomas","volume":"294","author":"Li","year":"2020","journal-title":"Radiology."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40478-018-0523-3","article-title":"Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry","volume":"6","author":"Longuesp\u00e9e","year":"2018","journal-title":"Acta Neuropathol Commun."},{"issue":"19","key":"10.1016\/j.jns.2023.120584_bb0140","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1460-9568.2002.02055.x","article-title":"NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria","volume":"16","author":"K\u00f6lker","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.jns.2023.120584_bb0150","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noac003","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2023.120584_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","article-title":"mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis","volume":"107","author":"Citraro","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.jns.2023.120584_bb0160","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4161\/cc.9.12.11866","article-title":"Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?","volume":"9","author":"Zeng","year":"2010","journal-title":"Cell Cycle"},{"issue":"7793","key":"10.1016\/j.jns.2023.120584_bb0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature."},{"issue":"7793","key":"10.1016\/j.jns.2023.120584_bb0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature."},{"issue":"8","key":"10.1016\/j.jns.2023.120584_bb0175","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/glia.22312","article-title":"Astrocyte immune responses in epilepsy","volume":"60","author":"Aronica","year":"2012","journal-title":"Glia."},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022434","article-title":"Role of astrocytes in epilepsy","volume":"5","author":"Coulter","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"6","key":"10.1016\/j.jns.2023.120584_bb0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/nan.12596","article-title":"Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations","volume":"46","author":"Zimmer","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.jns.2023.120584_bb0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-021-02348-6","article-title":"Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy","volume":"142","author":"Zimmer","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13311-013-0251-0","article-title":"Epilepsy related to developmental tumors and malformations of cortical development","volume":"11","author":"Aronica","year":"2014","journal-title":"Neurotherapeutics."},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2023.120584_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","article-title":"Inflammation in epilepsy: clinical observations","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia."},{"key":"10.1016\/j.jns.2023.120584_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-10-12","article-title":"Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions","volume":"10","author":"Prabowo","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"issue":"12","key":"10.1016\/j.jns.2023.120584_bb0215","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41582-022-00727-5","article-title":"Astrocytes in the initiation and progression of epilepsy","volume":"18","author":"Vezzani","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2023.120584_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clinph.2021.08.025","article-title":"High frequency oscillations associate with neuroinflammation in low-grade epilepsy associated tumors","volume":"133","author":"Sun","year":"2022","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2023.120584_bb0225","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","first-page":"618","article-title":"Glia-neuronal interactions in ictogenesis and epileptogenesis: Role of inflammatory mediators","author":"Vezzani","year":"2012"},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.064","article-title":"Glioma-induced alterations in neuronal activity and neurovascular coupling during disease progression","volume":"31","author":"Montgomery","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jns.2023.120584_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720981878","article-title":"Valproic acid enhanced apoptosis by promoting autophagy via Akt\/mTOR signaling in glioma","volume":"29","author":"Han","year":"2020","journal-title":"Cell Transplant."},{"issue":"10","key":"10.1016\/j.jns.2023.120584_bb0240","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.jns.2023.120584_bb0245","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noq044","article-title":"Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide","volume":"12","author":"Bobustuc","year":"2010","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0250","doi-asserted-by":"crossref","first-page":"10783","DOI":"10.1038\/s41598-020-67697-w","article-title":"Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy","volume":"10","author":"Roh","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jns.2023.120584_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225599","article-title":"Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: a retrospective, single-center","volume":"14","author":"Ryu","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0260","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-021-03940-2","article-title":"The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis","volume":"156","author":"Chen","year":"2022","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.jns.2023.120584_bb0265","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/jpm11050390","article-title":"Synergistic effect of Perampanel and Temozolomide in human glioma cell lines","volume":"11","author":"Salmaggi","year":"2021","journal-title":"J Pers Med."},{"issue":"9","key":"10.1016\/j.jns.2023.120584_bb0270","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2023.120584_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.598266","article-title":"Perampanel add-on to standard radiochemotherapy in vivo promotes neuroprotection in a rodent F98 glioma model","volume":"14","author":"Lange","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-017-0546-9","article-title":"In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells","volume":"36","author":"Rizzo","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme inducing and non-enzyme inducing anti-epileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Oberndorfer","year":"2005","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0290","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Barker","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"7","key":"10.1016\/j.jns.2023.120584_bb0295","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"12","key":"10.1016\/j.jns.2023.120584_bb0300","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology."},{"issue":"7","key":"10.1016\/j.jns.2023.120584_bb0305","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.jns.2023.120584_bb0310","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.3390\/cancers13153770","article-title":"How about Levetiracetam in glioblastoma? An institutional experience and Meta-analysis","volume":"13","author":"Jabbarli","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.jns.2023.120584_bb0315","article-title":"The addition of Valproic acid to concurrent radiation therapy and temozolomide improves patient outcome: a correlative analysis of RTOG 0525, SEER and a phase II NCI trial","volume":"5","author":"Krauze","year":"2020","journal-title":"Cancer Stud Ther."},{"issue":"5","key":"10.1016\/j.jns.2023.120584_bb0320","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Krauze","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"28","key":"10.1016\/j.jns.2023.120584_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021147","article-title":"Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide: a nationwide population-based cohort study in Taiwan","volume":"99","author":"Kuo","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jns.2023.120584_bb0330","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000013005","article-title":"Effect of levetiracetam use duration on overall survival of isocitrate dehydrogenase wild-type glioblastoma in adults: an observational study","volume":"98","author":"Pallud","year":"2022","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.jns.2023.120584_bb0335","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-016-2054-8","article-title":"Valproic acid, compared to other anti-epileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II\/III gliomas treated with temozolomide","volume":"127","author":"Redjal","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2023.120584_bb0340","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fneur.2020.00592","article-title":"Perampanel confirms to be effective and well-tolerated as an add-on treatment in patients with brain tumor-related epilepsy (PERADET study)","volume":"11","author":"Coppola","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120584_bb0345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebcr.2018.09.003","article-title":"Adjunctive perampanel for glioma-associated epilepsy","volume":"10","author":"Dunn-Pirio","year":"2018","journal-title":"Epilepsy Behav Case Rep."},{"issue":"4361\u20136","key":"10.1016\/j.jns.2023.120584_bb0350","article-title":"Seizures and tumor progression in glioma patients with uncontrollable epilepsy treated with perampanel","volume":"38","author":"Izumoto","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jns.2023.120584_bb0355","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/00207454.2018.1555160","article-title":"Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis","volume":"129","author":"Maschio","year":"2019","journal-title":"Int J Neurosci."},{"key":"10.1016\/j.jns.2023.120584_bb0360","doi-asserted-by":"crossref","first-page":"106681","DOI":"10.1016\/j.eplepsyres.2021.106681","article-title":"Effect of PIK3CA variants on glioma-related epilepsy and response to treatment","volume":"175","author":"Tobochnik","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jns.2023.120584_bb0365","first-page":"286","article-title":"Perampanel in the treatment of a patient with glioblastoma multiforme without IDH1 mutation and without MGMT promotor methylation","volume":"83","author":"Rosche","year":"2015","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.jns.2023.120584_bb0370","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11060-017-2473-1","article-title":"Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations","volume":"133","author":"Vecht","year":"2017","journal-title":"J. Neuro-Oncol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:27:13Z","timestamp":1753907233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":74,"alternative-id":["S0022510X23000448"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120584","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy and brain tumors: Two sides of the same coin","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120584"}}